SCHEMBL31335573

SCHEMBL31335573

COc1ccc(C(=O)N2Cc3cccc(NC(=O)/C=C/CN(C)C)c3C2)c(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 8/20 0.43
HSP90B1 P14625 6/20 0.43
HSP90AA1 P07900 3/20 0.42
HSP90AB1 P08238 1/20 0.42
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CYP2C9 P11712 1/20 0.41
RAB9A P51151 1/20 0.41
EGFR P00533 2/20 0.39
FLT3 P36888 1/20 0.38
BLK P51451 1/20 0.38
CCNK O75909 2/20 0.38
CCNA2 P20248 2/20 0.38
CDK2 P24941 2/20 0.38
CDK7 P50613 2/20 0.38
CCNH P51946 2/20 0.38
MNAT1 P51948 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31335571 0.92 HSP90AB1 (0.51) TRAP1HSP90B1HSP90AA1HSP90AB1BTK
SCHEMBL31335609 0.88 TRAP1 (0.46) TRAP1HSP90B1HSP90AA1HSP90AB1EGFR
SCHEMBL31335563 0.88 CCNK (0.44) TRAP1HSP90B1HSP90AA1HSP90AB1EGFR
SCHEMBL31335688 0.88 HSP90AB1 (0.41) TRAP1HSP90B1HSP90AA1HSP90AB1EGFR
SCHEMBL31335748 0.85 HSP90AB1 (0.40) TRAP1HSP90AA1HSP90AB1BTK
SCHEMBL31335804 0.85 TRAP1 (0.42) TRAP1HSP90B1HSP90AA1HSP90AB1EGFR
SCHEMBL31335842 0.85 TRAP1 (0.44) TRAP1HSP90B1HSP90AA1HSP90AB1BTK
SCHEMBL31335549 0.84 HSP90AA1 (0.52) TRAP1HSP90B1HSP90AA1HSP90AB1
SCHEMBL31335762 0.84 HSP90AA1 (0.55) TRAP1HSP90B1HSP90AA1HSP90AB1
SCHEMBL31335599 0.84 HSP90AA1 (0.41) TRAP1HSP90AA1HSP90AB1EGFRCCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP claimed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO claimed
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO disclosed